Skip to main content
. Author manuscript; available in PMC: 2020 Jan 1.
Published in final edited form as: Transfusion. 2018 Oct 26;59(1):303–315. doi: 10.1111/trf.14966

TABLE 4.

FINAL MODELS FROM MULTIVARIABLE PROPORTIONAL HAZARDS REGRESSION ANALYSIS

Variable* Reference Group* Parameter
Estimate
Standard
Error
Chi
Square
P* Hazard
Ratio*
95% CI
A) RBC TRANSFUSION INDEPENDENCE MODEL
RBC in 10 Days Prior None −0.62 0.08 58.70 < .0001 0.54 0.46, 0.63
CD34+ Dose Category 79.50 < .0001
 Medium Large −0.22 0.09 6.50 0.01 0.80 0.68, 0.95
 Small Large −1.15 0.13 79.40 < .0001 0.32 0.25, 0.41
ABO Match 16.30 0.001
 Major mismatch Identical −0.46 0.12 15.60 < .0001 0.63 0.50, 0.79
 Bidirectional mismatch Identical 0.02 0.15 0.00 0.91 1.02 0.76, 1.37
 Minor mismatch Identical −0.14 0.14 1.00 0.31 0.87 0.67, 1.14
B) PLATELET TRANSFUSION INDEPENDENCE MODEL
Platelets in 10 Days Prior None −0.63 0.10 40.00 <.0001 0.53 0.44, 0.65
Diagnostic Category 18.40 <.0001
 Intermediate risk heme Standard risk heme −0.10 0.13 0.60 0.44 0.90 0.70, 1.17
 High risk heme Standard risk heme −0.11 0.15 0.50 0.48 0.90 0.66, 1.21
 Benign Standard risk heme −0.34 0.20 2.80 0.09 0.71 0.48, 1.06
 Solid tumor Standard risk heme 0.27 0.17 2.50 0.11 1.31 0.94, 1.83
Regimen Category 56.30 < .0001
 Bone marrow myeloablative PBSC myeloablative −0.88 0.14 37.70 < .0001 0.41 0.31, 0.55
 PBSC nonmyeloablative PBSC myeloablative 0.54 0.15 12.60 0.0004 1.72 1.28, 2.32
 TLD + PBSC nonmyeloablative PBSC myeloablative 0.27 0.13 4.40 0.04 1.32 1.02, 1.70
Time Period 23.60 < .0001
 2001-2005 2006-2010 −0.43 0.10 20.60 < .0001 0.65 0.54, 0.78
 1993-2000 2006-2010 −0.40 0.10 14.80 0.0001 0.67 0.55, 0.82
*

Notes and Definitions:

Categories listed in the “Variable” column are compared to the category listed in the “Reference Group” column.

P: The P value for overall significance of each variable in the model is shown in bold. Non-bolded P values are interpreted differently; they only help assess relative effects among different categories of the same variable (smaller suggests a stronger difference).

Hazard Ratio: The hazard ratio characterizes the ratio in instantaneous chance of becoming independent relative to those in the reference group; values greater than 1 reflect faster attainment of transfusion independence.